Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Primary extra-adrenal pheochromocytoma: positive I-123 MIBG imaging with negative I-131 MIBG imaging

Journal Article · · Clin. Nucl. Med.; (United States)
I-131 metaiodobenzylguanidine (I-131 MIBG) is a well established imaging agent that reliably detects pheochromocytoma. In some patients, however, I-131 MIBG may fail to localize pheochromocytoma. I-123 MIBG has several potential advantages over I-131 MIBG, and these advantages may enable locating pheochromocytomas which have eluded other techniques, including I-131 MIBG imaging. A patient with primary extra-adrenal pheochromocytoma is described who illustrates the superiority of I-123 MIBG for the imaging of pheochromocytoma.
Research Organization:
St. Joseph Mercy Hospital, Ann Arbor, MI
OSTI ID:
6576044
Journal Information:
Clin. Nucl. Med.; (United States), Journal Name: Clin. Nucl. Med.; (United States) Vol. 12; ISSN CNMED
Country of Publication:
United States
Language:
English